Top Markets
#1 Siren Siren +43.80%
#2 Seeker Seeker +24.90%
#3 Full Moon Full Moon +19.61%
#4 Wrapped NXM Wrapped NXM +12.15%
#5 Zora Zora +10.73%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +10.64%
#7 VVS Finance VVS Finance +9.99%
#8 Cryptopia Cryptopia +9.26%
#9 Axelar Axelar +8.27%
#10 Helium Helium +8.16%
Coin of the day
Siren Siren
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Intercept Pharmaceuticals, Inc. Intercept Pharmaceuticals, Inc.

Intercept Pharmaceuticals, Inc.

ICPT
Clasificación en acciones #12019
Intercept Pharmaceuticals, Inc. is a biopharmaceutical firm specializing in the... Intercept Pharmaceuticals, Inc. is a biopharmaceutical firm specializing in the advancement and market launch of therapies designed to treat progressive, non-viral liver conditions. Its operational reach spans the United States, Europe, and Canada. The company currently markets Ocaliva, a medication functioning as a farnesoid X receptor (FXR) agonist. This drug is approved for the treatment of primary biliary cholangitis (PBC) in adults, specifically when administered alongside ursodeoxycholic acid. Beyond its existing approved indications, Intercept is actively investigating Ocaliva's potential for additional uses, notably including nonalcoholic steatohepatitis (NASH). Concurrently, it is progressing other drug candidates through various clinical and preclinical stages of development. In a collaborative effort, the company holds a licensing agreement with Aralez Pharmaceuticals Canada Inc. to develop and commercialize bezafibrate in the United States. Intercept distributes its products through a dual approach, utilizing both its proprietary commercial organization and a network of external third-party distributors. The company was founded in 2002 and is headquartered in New York, New York.
Precio por acción
$19.00
Última sincronización: 2023-11-14
Capitalización bursátil
$629.64M
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Intercept Pharmaceuticals, Inc. (ICPT)

Categoría

Healthcare
Historial del precio de la acción de Intercept Pharmaceuticals, Inc. (ICPT)
Precio más alto de cierre: $18.99 el 2023-11-01

Precio más bajo de cierre: $19.35 el 2012-10-01
Historial del precio de la acción de Intercept Pharmaceuticals, Inc. desde 2012 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2023 39.35%
2022 -16.08%
2021 -46.76%
2020 -74.21%
2019 16.21%
2018 65.23%
2017 -41.82%
2016 -32.31%
2015 8.19%
2014 138.13%
2013 92.89%
2012 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $542.09 38.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 44.13%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.36 -12.82%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.18 473.58%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $759.27 7.20%
CH